#2FloEquity News: Two of our leaders, Paul Burton, JD, MBA and Sharon Ray, wrote this incredible and timely article for Fierce Healthcare and we’re excited to share it.
Funding to Black-led startups reached new heights in 2021, but we have a long way to go before we reach parity. We believe equitable funding for Black-led health tech startups, or those focused on solving health problems that disproportionately affect communities of color, should be prioritized even more.
That’s because equitable healthcare funding is the true foundation for health equity. It puts people of all economic and racial backgrounds on an equal playing field when it comes to getting and staying well.
Read the full article to learn why now is the time to double down on supporting health startups led by diverse founders who have innovative ideas to close gaps in care — and how we can make the biggest impact by:
– investing earlier and investing more
– providing mentorship and support, and
– building a community.
We’re proud to highlight three of our portfolio companies in this piece as well: 4D Healthware (led by Star* Cunningham), CancerIQ (led by Feyi Ayodele), and Temprian Therapeutics (led by Kettil Cedercreutz,PhD).
Vivacelle Bio Announces Early Results of its Phase IIa Clinical Trial of VBI-S for Improving Hypovolemia Due to Sepsis
#2FloEquityNews: There is promising news in the fight against sepsis— a life-threatening complication of an